Yong Yin
Jiangsu Key Laboratory Of Bioactive Natural Product Research And State Key Laboratory Of Natural Medicines
Nanjing, 210009, China
Nanjing, 210009, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Discovery of novel N-heterocycle-fused deoxypodophyllotoxin analogues as dual tubulin/PARP1 inhibitors for cancer treatment.
Journal: European journal of medicinal chemistry
Published: March 03, 2026
A multiple-responsive nano-prodrug combining chemo-differentiation-cancer stem cell inhibition toward triple-negative breast cancer.
Journal: Biomaterials science
Published: January 16, 2026
Wavelet-informed deep video denoising for Cherenkov imaging of radiation therapy.
Journal: Optics letters
Published: December 24, 2025
Discovery of novel benzylaniline derivatives containing chloroacetamide as GPX4 inhibitors with potential efficacy in triple-negative breast cancer.
Journal: European journal of medicinal chemistry
Published: July 16, 2025
Discovery of novel genipin derivatives as highly selective ferroptosis inducers for the treatment of triple-negative breast cancer.
Journal: European journal of medicinal chemistry
Published: April 17, 2025
Design and synthesis of genipine derivatives for the treatment of liver fibrosis by modulating TGF-β1/Smad signaling pathway.
Journal: European journal of medicinal chemistry
Published: April 17, 2025
Biomimetic vesicles engineered from modified tumour cells act as personalized vaccines for post-surgical cancer immunotherapy.
Journal: Nature nanotechnology
Published: October 23, 2024
Enhancing immunogenicity and release of in situ-generated tumor vesicles for autologous vaccines.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: October 23, 2024
Discovery of novel quinazoline derivatives as tubulin polymerization inhibitors targeting the colchicine binding site with potential anti-colon cancer effects.
Journal: European journal of medicinal chemistry
Published: September 10, 2024
Icariside II inhibits Epithelial-Mesenchymal transition in metastatic osteosarcoma by antagonizing the miR-194/215 cluster via PGK1.
Journal: Biochemical pharmacology
Published: August 24, 2024
Last Updated: 09/26/2026